Dalton, Greiner, Hartman, Maher & Co’s Nutraceutical International Co NUTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-164,597
| Closed | -$6.86M | – | 189 |
|
|
2017
Q2 | $6.86M | Sell |
164,597
-368,966
| -69% | -$13.2M | 0.4% | 94 |
|
|
2017
Q1 | $16.6M | Buy |
533,563
+15,902
| +3% | +$539K | 0.95% | 49 |
|
|
2016
Q4 | $18.1M | Sell |
517,661
-61,824
| -11% | -$1.96M | 1.06% | 36 |
|
|
2016
Q3 | $18.1M | Buy |
579,485
+360,972
| +165% | +$9.3M | 1.18% | 15 |
|
|
2016
Q2 | $5.06M | Buy |
218,513
+2,961
| +1% | +$70.5K | 0.31% | 98 |
|
|
2016
Q1 | $5.25M | Buy |
215,552
+2,580
| +1% | +$62.4K | 0.32% | 94 |
|
|
2015
Q4 | $5.5M | Sell |
212,972
-2,104
| -1% | -$51.7K | 0.32% | 94 |
|
|
2015
Q3 | $5.08M | Sell |
215,076
-43,736
| -17% | -$1.05M | 0.29% | 99 |
|
|
2015
Q2 | $6.4M | Buy |
258,812
+46,710
| +22% | +$985K | 0.33% | 100 |
|
|
2015
Q1 | $4.18M | Buy |
212,102
+27,071
| +15% | +$509K | 0.23% | 100 |
|
|
2014
Q4 | $3.99M | Buy |
185,031
+18,384
| +11% | +$399K | 0.22% | 98 |
|
|
2014
Q3 | $3.48M | Sell |
166,647
-7,907
| -5% | -$184K | 0.2% | 105 |
|
|
2014
Q2 | $4.17M | Sell |
174,554
-35,049
| -17% | -$860K | 0.22% | 100 |
|
|
2014
Q1 | $5.45M | Sell |
209,603
-9,937
| -5% | -$258K | 0.32% | 92 |
|
|
2013
Q4 | $5.88M | Sell |
219,540
-15,486
| -7% | -$384K | 0.34% | 92 |
|
|
2013
Q3 | $5.58M | Sell |
235,026
-4,158
| -2% | -$94.5K | 0.38% | 94 |
|
|
2013
Q2 | $4.89M | Buy |
+239,184
| New | +$4.52M | 0.38% | 95 |
|
Dalton, Greiner, Hartman, Maher & Co's NUTR Position: Q3 2017 in Review
Dalton, Greiner, Hartman, Maher & Co sold out of Nutraceutical International Co (NUTR) in Q3 2017, closing a stake of 164,597 shares — an estimated $6.86M sold.
Dalton, Greiner, Hartman, Maher & Co first reported a position in NUTR in Q2 2013 and held it in 17 quarters. The position peaked at $18.1M in Q3 2016. 0 funds tracked by Wall St. Rank hold NUTR as of Q3 2017.
- Dalton, Greiner, Hartman, Maher & Co reported no remaining Nutraceutical International Co position as of Q3 2017 after selling out during the quarter.
- Dalton, Greiner, Hartman, Maher & Co sold 164,597 Nutraceutical International Co shares in Q3 2017, an estimated $6.86M.
- Dalton, Greiner, Hartman, Maher & Co first reported a position in Nutraceutical International Co in Q2 2013 and held it in 17 quarters.
- Dalton, Greiner, Hartman, Maher & Co's Nutraceutical International Co position peaked at $18.1M in Q3 2016.
- 0 funds tracked by Wall St. Rank held Nutraceutical International Co as of Q3 2017.
Based on Dalton, Greiner, Hartman, Maher & Co's 13F filing for Q3 2017, filed 12 Oct 2017.